Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to 0.35.

  • Vanda Pharmaceuticals' Asset Utilization Ratio rose 1751.54% to 0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35, marking a year-over-year increase of 1751.54%. This contributed to the annual value of 0.3 for FY2024, which is 144.66% up from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Asset Utilization Ratio of 0.35 as of Q3 2025, which was up 1751.54% from 0.32 recorded in Q2 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Asset Utilization Ratio registered a high of 0.47 during Q1 2021, and its lowest value of 0.27 during Q1 2024.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.37 (2023), whereas its average is 0.37.
  • Per our database at Business Quant, Vanda Pharmaceuticals' Asset Utilization Ratio crashed by 3199.75% in 2024 and then surged by 1751.54% in 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.46 in 2021, then fell by 11.54% to 0.41 in 2022, then decreased by 26.27% to 0.3 in 2023, then grew by 2.29% to 0.31 in 2024, then rose by 13.26% to 0.35 in 2025.
  • Its Asset Utilization Ratio stands at 0.35 for Q3 2025, versus 0.32 for Q2 2025 and 0.31 for Q1 2025.